National Cancer Institute
Putrajaya, Malaysia
Cancer treatment center in Putrajaya
4, Jalan P7, Presint 7, 62250 Putrajaya, Wilayah Persekutuan Putrajaya
About National Cancer Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Universiti Putra Malaysia
4
Hoffmann-La Roche
2
Eli Lilly and Company
1
Kura Oncology, Inc.
1
National Cancer Center, Japan
1
United Therapeutics
1
mAbxience Research S.L.
1
Clinical Trials at National Cancer Institute
During the past decade, National Cancer Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
2017-06-01
2020-03-26
Completed
483
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
2017-10-25
2022-04-07
Completed
619
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2018-02-06
2020-02-27
Completed
627
Fast Track Recovery Surgery Among Gynecologic Oncology Patients
2017-10-03
2019-10-30
Completed
118
Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy
2018-11-05
2023-05-31
Active, not recruiting
284
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Available
The Impact of Artificial Intelligence Dietary Smartphone Application on Nutritional Status Among Cancer Patients
2021-05-01
2022-03-31
Completed
56
The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy
2021-05-01
2021-11-29
Completed
29
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "National Cancer Institute" #1 sponsor was "Universiti Putra Malaysia" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Kura Oncology, Inc." with 1 trials sponsored and "National Cancer Center, Japan"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Institute"
#1 collaborator was "National Cancer Institute, Malaysia" with 3 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at National Cancer Institute
According to Clinical.Site data, the most researched conditions in "National Cancer Institute" are
"Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervical Cancer" (1 trials), "Endometrial Cancer" (1 trials), "Fast Track Recovery Surgery" (1 trials) and "HNSCC" (1 trials). Many other conditions were trialed in "National Cancer Institute" in a lesser frequency.
Clinical Trials Intervention Types at National Cancer Institute
Most popular intervention types in "National Cancer Institute" are "Drug" (6 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Abemaciclib" (1 trials), "Carboplatin" (1 trials), "Dinutuximab" (1 trials) and "EU-approved Avastin®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Cancer Institute
The vast majority of trials in "National Cancer Institute" are
10 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at National Cancer Institute
Currently, there are NaN active trials in "National Cancer Institute".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in National Cancer Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Cancer Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".